Imunon IMNN
NASDAQ IMNN
$1.28 -0.04 (-3.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Imunon (IMNN) Asset Writedowns and Impairment (2017)

Updated

Imunon (IMNN) recorded Asset Writedowns and Impairment of $13.37 million in FY2022.

Analysis

Imunon (IMNN) Asset Writedowns and Impairment (2017) Analysis & Trends

  • Annual Asset Writedowns and Impairment has a five-year compound annual growth rate of 39.6% (FY2017 to FY2022).
  • The FY2022 figure is the lowest annual Asset Writedowns and Impairment since FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Imunon 5.97 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 2.52 Mn
API Access

Imunon Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IMNN&period=max&api_key=YOUR_API_KEY